At the end of the day it will make no difference to LT holders...

At the end of the day it will make no difference to LT holders once sales commence but it's always disappointing when investor sentiment is impacted negatively by positive milestones like this especially with the appointment of "Mr Michalewicz has extensive experience as an international business executive, specialising in start-ups, raising capital, technology commercialisation, sales and marketing strategy and execution, international expansion, corporate governance and mergers and acquisitions" from ANN 5 June 2017, did they not run this ANN past him!!
Surely someone of his experience could see the short term affect of the wording!
If LBT is to be the OZ NZ distributor they need to start talking it up now!
Benny like you I've been around since the PreviIsola deal with bioMerieux and LBT has been good to me and I'm back in for the next run, but lack of professionalism and business acumen is so frustrating as it doesn't seem to improve luckily it's the technology that will speak loudest.

Lauban, Post #:27431892, some updates from the lab over coming months would be appreciated, thx in advance